Cassava Sciences GAAP EPS of -$0.57 beats by $0.09

  • Cassava Sciences press release (NASDAQ:SAVA): Q4 GAAP EPS of -$0.57 beats by $0.09.
  • At December 31, 2024, cash and cash equivalents were $128.6 million, with no debt.

Leave a Reply

Your email address will not be published. Required fields are marked *